Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Company announcement – No. 49 / 2021 Zealand Pharma Hosts Conference Call on August 12 at 4 pm CET (10am ET) to Present Second Quarter Results for 2021 Copenhagen, DK and Boston,...
-
Company announcement – No. 47 / 2021 Zealand Pharma A/S – Final Transactions Under Share Repurchase Program Copenhagen, DK, 27 July 2021 - On June 29, 2021, Zealand Pharma A/S ("Zealand")...
-
Company announcement – No. 47 / 2021 Zealand Pharma A/S – Transaction Under Share Repurchase Program Copenhagen, DK and Boston, MA, 20 July 2021 - On June 29, 2021, Zealand Pharma A/S...
-
Company announcement – No. 46 / 2021 Zealand Pharma A/S – Transaction Under Share Repurchase Program Copenhagen 13 July 2021 - On June 29, 2021, Zealand Pharma A/S ("Zealand")...
-
Company announcement – No. 45/ 2021 ZEALAND PHARMA A/S - TRANSACTIONS UNDER SHARE REPURCHASE PROGRAM Copenhagen 6 July 2021 - On June 29, 2021, Zealand Pharma A/S ("Zealand") initiated a share...
-
Company announcement – No. 44/ 2021 Total number of shares and voting rights in Zealand Pharma at June 30, 2021 Copenhagen, DK and Boston, MA, June 30, 2021 – Zealand Pharma A/S (“Zealand”)...
-
Company announcement – No. 43/ 2021 Zealand Pharma to Present Data on Glepaglutide at the 17th Congress of the Intestinal Rehabilitation and Transplantation Association (CIRTA) Company to...
-
Company announcement – No. 42/ 2021 ZEALAND PHARMA A/S - SHARE BUY-BACK PROGRAM UNDER SAFE HARBOUR TO AQUIRE DANISH COMMON STOCK FOR EMPLOYEE INCENTIVE PROGRAMS On 29 June 2021, Zealand Pharma...
-
Company announcement – No. 41/ 2021 Zealand Pharma Announces U.S. Commercial Availability of ZEGALOGUE® (dasiglucagon) injection ZEGALOGUE now available in both an auto-injector and prefilled...
-
Company announcement – No. 40/ 2021 Zealand Pharma to Participate in LifeSci Nordic Biotech Summit Copenhagen, DK and Boston, MA, U.S. June 22, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no....